Melanoma/Skin Cancer News

Psoriasis patients taking methotrexate are nearly three times as likely to develop nonmelanoma skin cancer compared with those not taking the drug, according to a study.

The U.S. Preventive Services Task Force has concluded there is not enough evidence to recommend skin cancer screenings by primary care physicians in adolescents and adults without symptoms.

There is not yet enough evidence to adequately assess the benefit-harm balance of screening for skin cancer in asymptomatic adolescents and adults, according to a statement from the U.S. Preventive Services Task Force.

The addition of an mRNA-based cancer vaccine to pembrolizumab extended RFS among patients with resected high-risk melanoma, according to study results presented at American Association for Cancer Research Annual Meeting.

Incorporating mismatch repair screening into daily practice for the management of sebaceous carcinomas may help identify patients with Muir-Torre/Lynch syndrome, which causes genetic predisposition to certain cancers, according to a study.

In a phase 1 trial of mistletoe extract for patients with cancer, researchers at Johns Hopkins Kimmel Cancer Center found the therapy to not only be safe but also potentially beneficial to quality of life.

Solid organ transplantation, age and a history of cancer were significant host risk factors for multiple and subsequent cutaneous squamous cell carcinoma, according to a large chart review.

NEW ORLEANS — Having proven a low recurrence rate, two treatments of the 595 nm pulsed dye laser may be a viable therapy for nonmelanoma skin cancer on the hands of older adult patients, according to a poster presented here.

University of Chicago Medicine Comprehensive Cancer Center has joined the National Comprehensive Cancer Network as its 33rd member institution.

HHS on Monday released the National Cancer Plan, which includes eight goals and strategies to prevent cancer, reduce related mortality and improve the lives of people living with the disease.